Exane Derivatives’s Healthpeak Properties DOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-275
Closed -$124K 660
2016
Q3
$124K Buy
+275
New +$9.62K 0.02% 229
2016
Q2
Sell
-275
Closed -$48.3K 579
2016
Q1
$48.3K Buy
+275
New +$8.25K 0.01% 316

Other funds holding DOC

Exane Derivatives's DOC Position: Q2 2022 in Review

Exane Derivatives reduced its Healthpeak Properties (DOC) stake by 88% in Q2 2022, selling an estimated $2.85K and leaving 13 shares worth $337. The position accounts for ﹤0.01% of the portfolio, ranked #619.

Exane Derivatives first reported a position in DOC in Q4 2014 and has held it in 31 quarters since. The position peaked at $1.81M in Q1 2018. 613 funds tracked by Wall St. Rank hold DOC as of Q2 2022.

  • Exane Derivatives held 13 shares of Healthpeak Properties worth $337 as of Q2 2022.
  • Exane Derivatives sold 94 Healthpeak Properties shares in Q2 2022, an estimated $2.85K.
  • Healthpeak Properties made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #619 holding.
  • Exane Derivatives first reported a position in Healthpeak Properties in Q4 2014 and has held it in 31 quarters since.
  • Exane Derivatives's Healthpeak Properties position peaked at $1.81M in Q1 2018.
  • 613 funds tracked by Wall St. Rank held Healthpeak Properties as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.